Effect of a matrix metalloproteinase inhibitor (ONO-4817) on lung metastasis of murine renal cell carcinoma

Anticancer Research

Volumn 21, Issue 6 A, 2001, Pages 3845-3852

  Muraishi, Yasuhiro ^a   Mitani, Noriyasu ^a   Fuse, Hideki ^a   Saiki, Ikuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Angiogenesis; Experimental pulmonary metastasis model; Invasion; Matrix metalloproteinase inhibitor (MMPI); ONO 4817; Renal cell carcinoma; Renca

Indexed keywords

5 ETHOXYMETHOXY N HYDROXY 2 METHYL 4 (4 PHENOXYBENZAMIDO)PENTANAMIDE; GELATIN; GELATINASE A; MATRIGEL; MATRIX METALLOPROTEINASE INHIBITOR; MESSENGER RNA; N HYDROXY 5 ETHOXYMETHYLOXY 2 METHYL 4 (4 PHENOXYBENZOYL)AMINOPENTANAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CELL ADHESION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; FEMALE; KIDNEY CARCINOMA; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; FEMALE; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; PHENYL ETHERS; PROTEASE INHIBITORS;

EID: 0035570783     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. An assessment of the current use of human interferons in therapy of urological cancers
2. Immunotherapy for metastatic renal cell carcinoma
3. The role of matrix metalloproteinases and their inhibitors in tumor invasion, metastasis and angiogenesis
4. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma
5. Type-IV collagenases in invasive tumors
6. Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small cell lung carcinoma
7. Analysis of MT1-MMP and MMP-2 expression in human gastric cancers
8. Matrix metalloproteinase -1 is associated with poor prognosis in colorectal cancer
9. Matrix metalloprotenese 9 expression in primary human prostatic adenocarcinoma and benign hyperplasia
10. Progelatinase A mRNA expression in cell lines derived from tumors in patients with metastatic renal cell carcinoma correlates inversely with survival
11. Augmentation of type IV collagenase, laminin receptor, and Ki 67 proliferation antigen associated with human colon, gastric and breast carcinoma progression
12. Inhibiton of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases
13. Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma
14. Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma
15. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinase
16. Effect of matrix metalloproteinase inhibitors on tumor growth and spontaneous metastasis
17. Matrix metalloproteinase inhibitors as a novel anticancer strategy: A review with special focus on Batimastat and Marimastat
18. Anti-metastatic efficacy and safety of MMI-166, a selective matrix metalloproteinase inhibitor
19. Antitumor effects of angiogenesis inhibitor o-(chloroacetylcarbamoyl) fumagillol (TNP-470) against murine renal cell carcinoma
20. ONO-4817, an orally active matrix metalloproteinase inhibitor, prevents lipopolysaccharide-induced proteoglycan release from the joint cartilage in guinea pigs
21. A murine renal cell carcinoma
22. Investigation of tumor angiogenesis in an id mouse model: Role of host-tumor interactions
23. Inhibition of tumor angiogenesis by a synthetic cell-adhesive polypeptide containing the Arg-Gly-Asp(RGD) sequence of fibronectin, poly (RGD)
24. Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro
25. A modified invasion-3-(4, 5-dimetylthiazole-2-yl)-2, 5-diphenyltetrazolium bromide assay for quantitating tumor cell invasion
26. Tumor angiogenesis: Therapeutical implications
27. Angiogenesis and tumor metastasis
28. Cancer invasion and metastasis
29. Proteolytic remodeling of extracellular matrix
30. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats
31. Tumor dormancy in vivo by prevention of neovascularization
32. Anti-angiogenesis: New concept for therapy of solid tumors
33. Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma
34. Recent advances in matrix metalloproteinase inhibitor research
35. Effects of inhibitors of plasminogen activator, serine proteinases and collagenase IV on the invasion of basement membranes by metastatic cells
36. Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer
37. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor